prof. MUDr. Jiří Mayer, CSc.
Department head, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 3643, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 1633
2023
-
Gemtuzumab ozogamicin s Midostaurinem v intenzivní léčbě CD33/FLT3+ AML – aktualizovaná data.
Year: 2023, type: Conference abstract
-
Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial
Leukemia, year: 2023, volume: 37, edition: 10, DOI
-
High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience
Bone Marrow Transplantation, year: 2023, volume: 58, edition: 11, DOI
-
Hodnocení minimální zbytkové choroby u nemocných s De Novo akutní myeloidní leukemií léčených kombinovanou terapií Azacitidine a Venetoclax.
Year: 2023, type: Conference abstract
-
Charakteristika a výsledky léčby Ropegenterferonem ALFA2B u pacientů s Ph negativními myeloproliferacemi.
Year: 2023, type: Conference abstract
-
Inhibition of acute myeloid leukemia using palbociclib and ponatinib in a patient-derived xenograft model.
Year: 2023, type: Conference abstract
-
Je vysazení TKI po předchozí dvoustupňové redukci jejich dávky úspěšné a bezpečné? Aktuální stav celonárodní studie HALF u pacientů s chronickou myeloidní leukemií.
Year: 2023, type: Conference abstract
-
Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use
Annals of hematology, year: 2023, volume: 102, edition: 12, DOI
-
Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options
Cancer Medicine, year: 2023, volume: 12, edition: 13, DOI
-
Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 Trials
HemaSphere, year: 2023, volume: 7, edition: 11, DOI